Knowledge Hub

Latest Report On Global Resipiratory Drugs Market to grow at a CAGR of 6.48% during the period 2016-2020.

Press Release   •   May 16, 2016 08:45 EDT

Description

About Respiratory Ailments

Asthma, COPD, allergic rhinitis, pulmonary hypertension, cystic fibrosis, and IPF are some of the major respiratory diseases. Among these, asthma and COPD are the most prevalent worldwide. Environmental pollution, changing lifestyles, and hereditary factors are some of the common causes of respiratory diseases. Intranasal corticosteroids, antihistamines, immunosuppressants, bronchodilators, and leukotriene antagonists are the respiratory medicines that are commonly used for the treatment of mild-to-moderate respiratory diseases. However, the choice of drug depends on the type and severity of the disease.

Technavios analysts forecast the Global Respiratory Drugs Market to grow at a CAGR of 6.48% during the period 2016-2020.

Covered in this report

The report covers the present scenario and the growth prospects of the global respiratory drugs market for 2016-2020. To calculate the market size, the report considers the revenue generated from the sales of prescription and over-the-counter (OTC) drugs used to treat respiratory diseases.

The market is divided into the following segments based on geography:

Americas

APAC

EMEA

Download Free Sample Copy of this Report

Technavio's report, Global Respiratory Drugs Market 2016-2020, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market.

Key vendors

AstraZeneca

Boehringer Ingelheim

F.Hoffman La-Roche

GlaxoSmithKline

Merck

Novartis

Other prominent vendors

Abbott

Actavis

Afferent Pharmaceuticals

Alere

Almirall

Amgen

AptarGroup

Astellas

Aurobindo

Axis Shield

Baxter

Bayer

Biogen

Biotest

Bristol-Myers Squibb

Chiesi Farmaceutici

Cipla

Cytos

Dainippon Sumitomo

Dr. Reddy's Laboratories

FibroGen

Gilead Sciences

Glenmark

GNI Group Ltd

Horizon Pharma

ImmuneWorks

MediciNova

MedImmune

Mylan

Ono Pharmaceutical

Orchid Chemicals and Pharmaceuticals

Perrigo

Pfizer

Promedior

Prometheus

ProMetic Life Sciences

Ranbaxy

Rottapharm Madaus

Sanofi

Shionogi

Siemens Healthcare Diagnostics

Skyepharma

Sosei

Sunovion

Takeda Pharmaceutical

Teva

Theravance

United Therapeutics

Vectura

Vertex

Zai Lab

Market driver

Rise in prevalence of respiratory diseases

For a full, detailed list, view our report

Market challenge

Unknown etiology of asthma and idiopathic pulmonary fibrosis

For a full, detailed list, view our report

Market trend

Use of biologics

For a full, detailed list, view our report

Key questions answered in this report

What will the market size be in 2020 and what will the growth rate be?

What are the key market trends?

What is driving this market?

What are the challenges to market growth?

Who are the key vendors in this market space?

What are the market opportunities and threats faced by the key vendors?

What are the strengths and weaknesses of the key vendors?